Search
Search Results
##search.searchResults.foundPlural##
-
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4231PDF: 1446HTML: 1530Untitled: 207 -
Spontaneous rupture of malarial spleen: report of two cases
767PDF: 388HTML: 2855jdoe, cover letter.doc: 158 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2040PDF: 832HTML: 294 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1236PDF: 977HTML: 105 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
892PDF: 324HTML: 164 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2084PDF: 1130HTML: 2571Study of serum haptoglobin level in thalassemia: 313Figures: 156 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3296PDF: 1240HTML: 2188Fi.1 Gritti.Rambaldi: 182 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3428PDF: 1124HTML: 4973Incidence age-standardized rates for HL across the Mediterranean basin: 172 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3510PDF: 1075HTML: 23314 -
-
Pidotimod in paucisymptomatic SARS-CoV2 infected patients Pidotimod in COVID-19
2951PDF: 1840HTML: 956 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2250PDF: 935HTML: 7604Untitled: 253Fig2: 162Fig3: 142Fig4: 160 -
-
CANDIDEMIA IN PATIENTS WITH ACUTE LEUKEMIA: ANALYSIS OF SEVEN YEARS’ EXPERIENCE AT A SINGLE CENTER IN CHINA Candidemia in acute Leukemia
1625PDF: 904HTML: 208 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3412PDF: 1571HTML: 2661 -
BIOLOGY OF HUMAN MALARIA PLASMODIA INCLUDING PLASMODIUM KNOWLESI
5103PDF: 2483HTML: 30074Antinori Tables 1,2,3: 314 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1348PDF: 474HTML: 3940 -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2483PDF: 794HTML: 14926Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 267 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1599PDF: 697HTML: 2326 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
521PDF: 324HTML: 71 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10284PDF: 6166HTML: 21737 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1212PDF: 512HTML: 22989 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1437PDF: 687HTML: 213 -
QUALITY OF LIFE IN PATIENTS WITH THALASSEMIA MAJOR AND INTERMEDIA IN KERMAN-IRAN (I.R.)
1596PDF: 716HTML: 2323Cover Letter: 155 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1859PDF: 702HTML: 677 -
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1126PDF: 744HTML: 205







